Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines.
about
Low dose tubulin-binding drugs rescue peroxisome trafficking deficit in patient-derived stem cells in Hereditary Spastic Paraplegia.The Use of Liposomes and Nanoparticles as Drug Delivery Systems to Improve Cancer Treatment in Dogs and Cats.Patient-Derived Stem Cell Models in HSP: Disease Modelling and Drug Discovery
P2860
Nanoparticulate paclitaxel demonstrates antitumor activity in PC3 and Ace-1 aggressive prostate cancer cell lines.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Nanoparticulate paclitaxel dem ...... ve prostate cancer cell lines.
@en
Nanoparticulate paclitaxel dem ...... ve prostate cancer cell lines.
@nl
type
label
Nanoparticulate paclitaxel dem ...... ve prostate cancer cell lines.
@en
Nanoparticulate paclitaxel dem ...... ve prostate cancer cell lines.
@nl
prefLabel
Nanoparticulate paclitaxel dem ...... ve prostate cancer cell lines.
@en
Nanoparticulate paclitaxel dem ...... ve prostate cancer cell lines.
@nl
P2093
P2860
P50
P1476
Nanoparticulate paclitaxel dem ...... ve prostate cancer cell lines.
@en
P2093
Charles J Decedue
Jahna Espinosa
Kim A Selting
Kristin K Dank
Nicole A Clarkson
Senthil R Kumar
P2860
P2888
P304
P356
10.1007/S10637-013-0006-0
P577
2013-09-13T00:00:00Z